Table 1.
Treatment | Tumor Cell Lines | |||
---|---|---|---|---|
K562 | HeLa | HepG2 | KB-3-1 | |
Paclitaxel alone (Control) | 4.8 ± 0.4 | 17.1 ± 4.1 | 67.2 ± 12.3 | 8.1 ± 1.3 |
Paclitaxel + 10 μg/mL ETA | 3.8 ± 0.6 | 8.3 ± 1.0 * | 14.1 ± 8.5 ** | 5.1 ± 0.6 * |
Treatment | Tumor Cell Lines | |||
---|---|---|---|---|
K562 | HeLa | HepG2 | KB-3-1 | |
Paclitaxel alone (Control) | 4.8 ± 0.4 | 17.1 ± 4.1 | 67.2 ± 12.3 | 8.1 ± 1.3 |
Paclitaxel + 10 μg/mL ETA | 3.8 ± 0.6 | 8.3 ± 1.0 * | 14.1 ± 8.5 ** | 5.1 ± 0.6 * |